This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Kadant (KAI) Buys Syntron Material Handling for $179M in Cash
by Zacks Equity Research
Kadant's (KAI) Syntron Material Handling buyout to expand its growth opportunities in process industries.
Here's Why You Should Avoid Betting on Roper (ROP) Stock Now
by Zacks Equity Research
Roper (ROP) might suffer from high costs and operating expenses, increase in tax rate for the fourth quarter, huge debt levels, and integration woes.
Applied Industrial Battles Cost Woes, Growth Prospects Solid
by Zacks Equity Research
Rising cost might hurt Applied Industrial's (AIT) near-term profits. However, the company's solid buyout and sales prospects remain tailwinds.
Actuant Gains From Inorganic Moves, Cost Concerns Prevail
by Zacks Equity Research
Actuant (ATU) gains from solid sales, pricing initiatives and inorganic initiatives. However, rising cost remains a cause of worry.
Middleby Buys EVO America, Expands Ventless Cooking Business
by Zacks Equity Research
Middleby's (MIDD) EVO America buyout to expand its ventless cooking equipment offerings in the commercial foodservice industry.
Here's Why You Should Avoid Betting on Xylem (XYL) Stock Now
by Zacks Equity Research
Xylem (XYL) might suffer from rising cost of sales (due to implementation of tariffs), high operating expenses, unfavorable movements in foreign currencies and high debts.
Stanley Black to Launch Two Innovative Solutions in CES
by Zacks Equity Research
Stanley Black (SWK) to display two new innovative solutions (PRIA by BLACK+DECKER) and (OMNI) in the upcoming Consumer Electronics Show.
Here's Why You Should Consider Buying EnerSys (ENS) Stock Now
by Zacks Equity Research
EnerSys (ENS) stands to gain from strengthening end-market demand, pricing actions, solid product portfolio and restructuring moves. Also, acquired assets are a boon.
Santa Finally Arrives on Wall Street: ETFs & Stocks to Bet on
by Sweta Killa
After days of painful losses, Wall Street made a roaring comeback after Christmas. These ETFs & stocks are intriguing choices to play the Santa rally for a short spell.
Here's Why You Should Avoid Betting on A. O. Smith (AOS) Now
by Zacks Equity Research
A. O. Smith (AOS) is likely to suffer from weak business in China, ailing water heater industry in the United States, high costs and expenses, and forex woes.
Here's Why Investors Should Avoid Nordson (NDSN) Stock Now
by Zacks Equity Research
Nordson (NDSN) is likely to suffer from rising cost of sales and operating expenses, forex woes and high debt levels.
Altra Industrial Gains From Solid Sales, Costs Remain High
by Zacks Equity Research
Altra Industrial (AIMC) is poised to gain from solid end-market sales, restructuring moves and strategic business acquisitions. However, rising cost remains a drag.
Here's Why You Should Buy Ingersoll-Rand (IR) Stock Now
by Zacks Equity Research
Ingersoll-Rand (IR) grows on the back of stellar sales, greater operational efficacy, pricing actions and strategic acquisitions.
Here's Why You Should Avoid Betting on IDEX (IEX) Stock Now
by Zacks Equity Research
IDEX (IEX) might suffer from rising cost of sales and operating expenses, high debts, and unfavorable movements in foreign currencies.
Here's Why You Should Hold on to Fortune Brands (FBHS) Now
by Zacks Equity Research
Fortune Brands (FBHS) is poised to gain from buyouts and shareholder-friendly policies. High costs and debts, as well as exposure to natural calamities, are creating headwinds.
Here's Why it is Worth Investing in Colfax (CFX) Stock Now
by Zacks Equity Research
Colfax (CFX) to gain from strengthening end markets, productivity initiatives, pricing actions and lower taxes. Also, acquisitions, including the DJO Global buyout after completion, will aid.
Cintas (CTAS) Tops Q2 Earnings Estimates, Raises FY19 View
by Zacks Equity Research
Cintas' (CTAS) second-quarter fiscal 2019 earnings surpass the Zacks Consensus Estimate by 2.3%.
Actuant (ATU) Beats Q1 Earnings Estimates, Lowers Sales View
by Zacks Equity Research
Actuant's (ATU) first-quarter fiscal 2019 results gain from organic sales growth and rise in margins. The company maintains earnings projection for fiscal 2019 while revises down sales estimates.
Colfax (CFX) Provides Financial Projections for 4Q18 and 2019
by Zacks Equity Research
Colfax (CFX) benefits from healthy segmental business, acquisitions and restructuring moves. It provides segmental projections for 2019 and briefs on estimates for the fourth quarter and 2018.
Luxfer's Neo Performance Buyout to Boost Earnings Prospects
by Zacks Equity Research
Luxfer (LXFR) will acquire Neo Performance Materials in order to become the primary highly-engineered advanced materials manufacturer in the market.
Colfax Secures $3B Bank Financing to Fund DJO Global Buyout
by Zacks Equity Research
Colfax (CFX) raises roughly $3 billion through bank financing from the group of 23 banks, which will fund the company's acquisition of DJO Global.
Xylem to Drive Water-Industry Innovation on Imagine H2O Deal
by Zacks Equity Research
Xylem (XYL) will partner with Imagine H2O for supporting the start-up companies of the latter's flagship accelerator program.
Colfax (CFX) Gains From Buyouts, High Costs Remain a Drag
by Zacks Equity Research
Colfax (CFX) benefits from solid business opportunities created by acquired assets. DJO Global, after acquisition, will mark Colfax's entry to the orthopedic market. However, high costs remain a drag.
Flowserve (FLS) Discusses Long-Term Goals & Growth Strategies
by Zacks Equity Research
On the Analyst Day, Flowserve (FLS) emphasizes its growth strategies and merger of two business segments into one, and provides targets for a four-year period from 2019 till 2022.
Emerson Acquires A.E. Valves to Fortify Technology Portfolio
by Zacks Equity Research
Emerson (EMR) acquires A.E. Valves in order to strengthen its critical isolation and valve technologies portfolio.